Literature DB >> 28925573

Achieving recovery in patients with schizophrenia through psychosocial interventions: A retrospective study.

Mariachiara Buonocore1, Marta Bosia1,2, Maria A Baraldi3, Margherita Bechi1, Marco Spangaro1,2, Federica Cocchi1, Laura Bianchi1, Carmelo Guglielmino1, Antonella R Mastromatteo1,2, Roberto Cavallaro1,2.   

Abstract

AIM: Recovery, or functional remission, represents the ultimate treatment goal in schizophrenia. Despite its importance, a standardized definition of remission is still lacking, thus reported rates significantly vary across studies. Moreover, the effects of rehabilitative interventions on recovery have not been thoroughly investigated. This study aimed to evaluate recovery in a sample of patients with chronic schizophrenia engaged in rehabilitation programs and to explore contributing factors, with a focus on sociocognitive rehabilitative interventions.
METHODS: Data from 104 patients with schizophrenia treated either with a standard rehabilitation program, including cognitive remediation (n = 46), or the latter plus a specific sociocognitive intervention (n = 58), and assessed for psychopathology, cognition, social cognition, and Quality of Life Scale, were retrospectively analyzed for this study.
RESULTS: Recovery, evaluated with the Quality of Life Scale, was achieved by 56.76% of patients in our sample. While no effects were observed for clinical, cognitive, or sociocognitive variables, participation in the sociocognitive rehabilitative interventions was positively associated with recovery.
CONCLUSION: Our results indicate that high rates of recovery can be achieved in patients treated with psychosocial interventions and suggest that rehabilitative programs targeting social cognition may further facilitate the process of recovery. If confirmed, these results may have relevant implications for daily clinical practice and service provision, allowing clinicians to develop and optimize specific rehabilitation programs in order to promote recovery.
© 2017 The Authors. Psychiatry and Clinical Neurosciences © 2017 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  functional remission; neuropsychology; psychosis; quality of life; theory of mind

Mesh:

Year:  2017        PMID: 28925573     DOI: 10.1111/pcn.12605

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  6 in total

1.  The Effect of Mindfulness-Based Psychosocial Skills Training on Functioning and Insight Level in Patients with Schizophrenia.

Authors:  Arzu Yüksel; Emel Bahadır-Yılmaz
Journal:  Community Ment Health J       Date:  2020-06-13

2.  A 1.5-Year Longitudinal Study of Social Activity in Patients With Schizophrenia.

Authors:  Kazutaka Ohi; Chika Sumiyoshi; Haruo Fujino; Yuka Yasuda; Hidenaga Yamamori; Michiko Fujimoto; Tomiki Sumiyoshi; Ryota Hashimoto
Journal:  Front Psychiatry       Date:  2019-08-09       Impact factor: 4.157

Review 3.  Eye movement characteristics in schizophrenia: A recent update with clinical implications.

Authors:  Kentaro Morita; Kenichiro Miura; Kiyoto Kasai; Ryota Hashimoto
Journal:  Neuropsychopharmacol Rep       Date:  2019-11-27

4.  Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.

Authors:  Yoshikazu Takaesu; Koichiro Watanabe; Shusuke Numata; Masaaki Iwata; Noriko Kudo; Satoru Oishi; Takeya Takizawa; Kiyotaka Nemoto; Yuka Yasuda; Hiromi Tagata; Takashi Tsuboi; Naohisa Tsujino; Naoki Hashimoto; Yuki Matsui; Hikaru Hori; Hidenaga Yamamori; Nobuhiro Sugiyama; Taro Suwa; Taishiro Kishimoto; Akitoyo Hishimoto; Masahide Usami; Ryuji Furihata; Kunihiro Iwamoto; Hiroshige Fujishiro; Toshinori Nakamura; Kentaro Mizuno; Takahiko Inagaki; Eiichi Katsumoto; Hiroaki Tomita; Kazutaka Ohi; Hiroyuki Muraoka; Kiyokazu Atake; Hitoshi Iida; Tatsuya Nagasawa; Junichi Fujita; Satoshi Yamamura; Toshiaki Onitsuka; Atsunobu Murata; Yoichiro Takayanagi; Hokuto Noda; Yukiko Matsumura; Kenji Takezawa; Jun-Ichi Iga; Kayo Ichihashi; Kazuyoshi Ogasawara; Hisashi Yamada; Ken Inada; Ryota Hashimoto
Journal:  Psychiatry Clin Neurosci       Date:  2019-08-22       Impact factor: 5.188

5.  Cognitive and clinical predictors of community functioning across the psychoses.

Authors:  Kathryn E Lewandowski; Talia R Cohen; Dost Ongur
Journal:  Psych J       Date:  2020-03-24

6.  Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile.

Authors:  Renato de Filippis; Raffaele Gaetano; Georgios Schoretsanitis; Giuseppe Verde; Cesare Anthony Oliveti; John M Kane; Cristina Segura-Garcia; Pasquale De Fazio
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-01       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.